查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829327

2025年全球藥物釋放型球囊導管市場報告

Drug Eluting Balloons Catheters Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物釋放型球囊導管市場規模迅速擴張，從2024年的14.3億美元成長到2025年的16.5億美元，複合年成長率為15.4%。預測期內的成長可歸因於呼吸系統疾病的增多、藥物洗脫球囊導管優於傳統吸入器的優勢、患者對藥物洗脫球囊導管的偏好、政府在呼吸健康方面的舉措、戰略聯盟與夥伴關係關係、藥物製劑的進步以及老年人口的成長。

預計未來幾年藥物釋放型球囊導管市場將快速成長，到2029年將達到26.2億美元，複合年成長率為12.2%。預測期內成長的主要促進因素包括呼吸系統疾病的持續成長、老年人口的成長、認知度和教育水平的提高、新興國家的市場擴張、定製藥物配方、監管支持和合規性以及包裝和設計的創新。預測期內的主要趨勢包括智慧吸入器及其連接性、向呼吸驅動吸入器的轉變、關注兒科和老年患者的需求、生技藥品的輸送以及環保的吸入器設計。

藥物釋放型球囊導管是一種用於經經皮冠狀動脈介入治療 (PCI) 治療冠狀動脈疾病的醫療設備。它們是半相容血管成形術球囊，表面塗有抗增生藥物。在球囊充氣過程中，藥物會釋放到血管壁，防止血管再阻塞並降低晚期血栓症的風險，且無需植入永久性異物。

藥物釋放型球囊導管主要用於治療冠狀動脈疾病和周邊血管疾病。用於治療冠狀動脈疾病的藥物釋放型球囊導管採用親油性基質，將抗增殖藥物直接輸送至血管壁，無需使用金屬人工替代物或不可分解聚合物等永久性結構。導管可使用多種藥物，包括紫杉醇和Sirolimus，導管由尼龍和聚氨酯等材料製成。導管廣泛應用於醫院、診所、門診手術中心和導管室。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在尋求透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告提供藥物釋放型藥物釋放型容器的市場統計數據，包括全球市場規模、區域佔有率、藥物釋放型球囊容器市場佔有率競爭對手、藥物釋放型球囊容器的詳細細分市場、市場趨勢和商機，以及在藥物釋放型球囊容器行業取得成功所需的數據。本研究報告提供了藥物釋放型球囊容器市場的所有資訊，並對該行業的現狀和未來趨勢進行了深入分析。

未來五年預測成長率為12.2%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自法國和義大利等主要地區的紫杉醇塗層技術和球囊擴張控制器徵收關稅直接影響美國，從而可能導致周邊動脈疾病的治療選擇減少，介入放射學費用上升。此外，透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響將更為廣泛。

預計周邊和心血管疾病的日益普及將推動未來藥物釋放型球囊導管市場的成長。心血管疾病 (CVD) 包括多種​​影響心臟和循環系統的疾病，而周邊動脈疾病(PAD) 則具體涉及動脈狹窄，主要導致流向手臂和腿部的血流減少。藥物釋放型球囊導管用於治療冠狀動脈疾病 (CAD)，其特徵是半相容血管成形術用氣球，塗有抗增殖藥物，一旦進入血管即可發揮抗血管再阻塞作用。例如，美國政府機構美國疾病管制與預防中心 (CDC) 在 2024 年 5 月報告稱，心臟病將在 2022 年導致 702,880 人死亡，佔總死亡人數的五分之一。美國每年約有80.5萬人心臟病發作，其中約60.5萬人為首次心臟病發作，20萬人曾罹患心臟病。因此，周邊和心血管疾病的盛行率不斷上升，推動了藥物釋放型球囊導管市場的發展。

微創手術需求的不斷成長預計將進一步推動藥物釋放型球囊導管市場的成長。微創手術切口小，癒合時間更快，疼痛更少，感染風險更低。藥物釋放型球囊在這些治療中至關重要，它透過將藥物直接輸送到治療部位來防止血管再阻塞並提高血管干預的有效性。例如，Intuitive Surgical Inc. 報告稱，使用其 Vinci 手術系統的手術數量將從 2021 年的 1,594,000 例增加 18%，到 2022 年將達到 1,875,000 例。此外，美國整形外科醫師協會指出，到 2022 年，美國的微創美容手術數量將增加到 23,672,269 例。因此，微創手術需求的不斷成長正在推動藥物釋放型球囊導管市場的成長。

為了確保競爭優勢，藥物釋放型球囊導管市場的主要參與者正在加緊開發配備先進技術的下一代產品。例如，2024年3月，美國生物醫學和生物技術工程公司波士頓科學宣布其AGENT藥物塗層球囊（DCB）已獲得美國食品藥物管理局（FDA）的核准。本產品是美國第一個專門用於治療支架內血管再阻塞（ISR）的藥物塗層冠狀動脈球囊。 AGENT DCB採用紫杉醇塗層，可輸送治療劑量，有效降低ISR復發，無需額外支架或放射治療。臨床試驗顯示，不利事件發生率低，標靶部位心臟病發作風險降低49%。

2023年6月，Translumina Therapeutics公司收購了Blue Medical Devices BV，收購金額未揭露。這項策略性收購旨在將Blue Medical專有的藥物輸送技術整合到Translumina的產品線中，擴大其神經血管和周邊介入產品線，並增強其藥物輸送能力。 Blue 醫療設備 BV是一家總部位於荷蘭的醫療器材製造商，專門生產藥物釋放型球囊導管。

藥物釋放型球囊導管市場包括依Everolimus和 Stellarex 的銷售。該市場的價值為“出廠價”，即產品製造商或創造者銷售的產品價值，無論是銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥物釋放型球囊導管：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球藥物釋放型球囊導管市場：成長率分析
  • 全球藥物釋放型球囊導管市場表現：規模與成長，2019-2024
  • 全球藥物釋放型球囊導管市場預測：規模與成長，2024-2029年，2034年
  • 全球藥物釋放型球囊導管：總目標市場（TAM）

第6章 市場細分

  • 全球藥物釋放型球囊導管市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 用於治療冠狀動脈疾病的藥物釋放型球囊導管
  • 用於治療周邊血管疾病的藥物釋放型球囊導管
  • 全球藥物釋放型球囊導管市場（依藥物、實際及預測）2019-2024 年、2024-2029 年、2034 年
  • 紫杉醇
  • Sirolimus
  • 其他藥物
  • 全球藥物釋放型球囊導管市場：依材料、實際結果及預測，2019-2024 年、2024-2029 年、2034 年
  • 尼龍
  • 聚氨酯
  • 其他成分
  • 全球藥物釋放型球囊導管市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 門診手術中心
  • 導管室
  • 全球藥物釋放型球囊導管市場：依冠狀動脈疾病（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型球囊導管
  • 一般球囊導管
  • 全球藥物釋放型球囊導管市場：依周邊血管疾病（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型球囊導管
  • 血管成形術用氣球導管
  • 全球藥物釋放型球囊導管市場：血管成形術用氣球導管細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型血管成形術用氣球導管

第7章 區域和國家分析

  • 全球藥物釋放型球囊導管市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球藥物釋放型球囊導管市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 藥物釋放型球囊導管市場：競爭格局
  • 藥物釋放型球囊導管市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • B Braun Melsungen Aktiengesellschaft
  • Terumo Corporation
  • Cook Medical LLC
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Acotec Scientific Co. Ltd.
  • Cordis Corporation
  • Biosensors International Group Ltd.
  • Zylox-Tonbridge Medical Technology Co. Ltd.
  • Mermaid Medical AS
  • Hexacath Limited
  • Zhejiang Barty Medical Technology Co. Ltd.
  • Cardionovum GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年藥物釋放型球囊導管市場：提供新機會的國家
  • 2029年藥物釋放型球囊導管市場：細分市場帶來新機會
  • 2029年藥物釋放型球囊導管市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27948u

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.62 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs.

The forecast of 12.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on paclitaxel-coating technologies and balloon expansion controllers, sourced from key regions such as France and Italy, which could lead to reduced peripheral artery disease treatment options and higher interventional radiology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of peripheral and cardiovascular diseases is anticipated to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that diminishes blood flow mainly to the arms or legs. Drug-eluting balloon catheters are utilized in the treatment of coronary artery disease (CAD); they feature a semi-compliant angioplasty balloon coated with an anti-proliferative agent that exerts an anti-restenotic effect upon entering the vessel. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, heart disease was responsible for 702,880 deaths, representing 1 in every 5 fatalities. Annually, around 805,000 individuals in the United States suffer a heart attack, with approximately 605,000 being their first heart attack and 200,000 occurring in those who have previously experienced one. Thus, the rising prevalence of peripheral and cardiovascular diseases is propelling the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Subsegments:
  • 1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters; Plain Balloon Catheters
  • 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Angioplasty Balloon Catheters
  • 3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation; B Braun Melsungen Aktiengesellschaft; Terumo Corporation; Cook Medical LLC; Lepu Medical Technology Co. Ltd.; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; BIOTRONIK SE & Co. KG; Acotec Scientific Co. Ltd.; Cordis Corporation; Biosensors International Group Ltd.; Zylox-Tonbridge Medical Technology Co. Ltd.; Mermaid Medical AS; Hexacath Limited; Zhejiang Barty Medical Technology Co. Ltd.; Cardionovum GmbH; Nano Therapeutics Pvt. Ltd.; Tokai Medical Products Inc.; Opto Circuits Limited; Acrostak (Schweiz) AG; Machine Solutions Inc.; Concept Medical Inc.; Aachen Resonance GmbH; AR Baltic Medical UAB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Eluting Balloons Catheters Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Eluting Balloons Catheters Market Growth Rate Analysis
  • 5.4. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM)

6. Drug Eluting Balloons Catheters Market Segmentation

  • 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Artery Disease Drug-Eluting Balloon Catheters
  • Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nylon
  • Polyurethane
  • Other Raw Materials
  • 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • 6.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Balloon Catheters
  • Plain Balloon Catheters
  • 6.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Balloon Catheters
  • Angioplasty Balloon Catheters
  • 6.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Angioplasty Balloon Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Angioplasty Balloon Catheters

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Eluting Balloons Catheters Market

  • 9.1. China Drug Eluting Balloons Catheters Market Overview
  • 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Eluting Balloons Catheters Market

  • 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

  • 11.1. Japan Drug Eluting Balloons Catheters Market Overview
  • 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

  • 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

  • 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

  • 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

  • 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

  • 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

  • 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Eluting Balloons Catheters Market

  • 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

  • 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

  • 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

  • 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

  • 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

  • 23.1. North America Drug Eluting Balloons Catheters Market Overview
  • 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

  • 24.1. USA Drug Eluting Balloons Catheters Market Overview
  • 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

  • 25.1. Canada Drug Eluting Balloons Catheters Market Overview
  • 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

  • 26.1. South America Drug Eluting Balloons Catheters Market Overview
  • 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

  • 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

  • 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

  • 29.1. Africa Drug Eluting Balloons Catheters Market Overview
  • 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
  • 30.2. Drug Eluting Balloons Catheters Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • 31.1. B Braun Melsungen Aktiengesellschaft
  • 31.2. Terumo Corporation
  • 31.3. Cook Medical LLC
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Meril Life Sciences Pvt. Ltd.
  • 31.6. MicroPort Scientific Corporation
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. Acotec Scientific Co. Ltd.
  • 31.9. Cordis Corporation
  • 31.10. Biosensors International Group Ltd.
  • 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
  • 31.12. Mermaid Medical AS
  • 31.13. Hexacath Limited
  • 31.14. Zhejiang Barty Medical Technology Co. Ltd.
  • 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

34. Recent Developments In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Eluting Balloons Catheters Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Balloons Catheters Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Balloons Catheters Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer